INTERNATIONAL PATENT: ABBVIE INC., ABBVIE DEUTSCHLAND GMBH & CO. KG FILES APPLICATION FOR "HIGH CONCENTRATION RISANKIZUMAB FORMULATIONS"

GENEVA, July 3 -- ABBVIE INC. (1 North Waukegan RoadNorth Chicago, IL 60064), ABBVIE DEUTSCHLAND GMBH & CO. KG (Mainzer Str. 8165189 Wiesbaden) filed a patent application (PCT/US2024/061124) for "HIGH CONCENTRATION RISANKIZUMAB FORMULATIONS" on Dec 19, 2024. With publication no. WO/2025/137347, the details related to the patent application was published on Jun 26, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): WANG, Chen (c/o AbbVie Inc.1 North Waukegan RoadNorth Chicago, IL 60064), GAZA-BULSECO, Georgeen (c/o AbbVie Inc.1 North Waukegan RoadNorth Chicago, IL 60064), GERVAIS, Johanna Linder...